For time‐to‐event analysis, IDH1/2 mutations were not associated with tumor RFS (HR = 0.63; 95% CI = 0.30–1.31; p = 0.21) and MFS (HR = 1.75; 95% CI = 0.91–3.36; p = 0.09), but they were significantly correlated with patient OS (HR = 1.81; 95% CI = 1.15–2.87; p = 0.01) (Figure 2). The gene discussed is IDH1; the disease is neoplasm.